Enablex became the property of Novartis earlier this year, when Pfizer sold it to avoid any marketing conflicts of interest when it acquired Pharmacia.
Novartis hire Ketchum
EAST HANOVER, NJ: Novartis has hired Ketchum to handle communications for Enablex, an overactive-bladder treatment currently awaiting approval from the Food and Drug Administration.
